| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Division of Endocrinology and Departments of Medicine (N.A., T.L.C.) Molecular and Cellular Physiology (M.F.C.-K.) and Orthopedic Surgery (T.S.G.), University of Cincinnati, Cincinnati, Ohio 45267
Address all correspondence and requests for reprints to: Thomas L. Clemens, Ph.D., University of Cincinnati, College of Medicine, Division of Endocrinology, Vontz Center for Molecular Studies, 3125 Eden Avenue, Cincinnati, Ohio 45267-0547.
VEGF is produced by osteoblasts and has been postulated to function as
an angiogenic stimulus during normal skeletal development and in
fracture repair. In this study, we characterized the molecular
mechanisms by which experimental hypoxia increases VEGF mRNA in human
MG63 osteoblast-like cells. Exposure of MG63 cells to 1%
O2 for 24 h resulted in a four-fold increase in VEGF mRNA.
Immunoblotting of nuclear extracts demonstrated a time-dependent
increase in the level of the Hif-2
protein, which preceded the rise
in VEGF mRNA. To determine the effect of hypoxia on VEGF gene
transcription, MG63 cells were transiently transfected with a segment
of the VEGF promoter construct fused to luciferase and then exposed to
1% O2. Hypoxia induced VEGF promoter activity five-fold by
24 h. Forced expression of Hif-2
, but not Hif-1
, increased both
basal and hypoxia induced VEGF promoter activity. By contrast, the
ability of the VEGF reporter to respond to hypoxia or recombinant
Hif-2
was abolished in cells transfected with a VEGF promoter
construct containing a mutation in the hypoxia response element. In
summary, exposure of osteoblast-like cells to hypoxia induces VEGF
expression via induction of Hif-2
and transcriptional activation of
the VEGF promoter.
This article has been cited by other articles:
![]() |
J. Dai and A.B.M. Rabie VEGF: an Essential Mediator of Both Angiogenesis and Endochondral Ossification J. Dent. Res., October 1, 2007; 86(10): 937 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ke and M. Costa Hypoxia-Inducible Factor-1 (HIF-1) Mol. Pharmacol., November 1, 2006; 70(5): 1469 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Carroll and M. Ashcroft Role of Hypoxia-Inducible Factor (HIF)-1{alpha} versus HIF-2{alpha} in the Regulation of HIF Target Genes in Response to Hypoxia, Insulin-Like Growth Factor-I, or Loss of von Hippel-Lindau Function: Implications for Targeting the HIF Pathway. Cancer Res., June 15, 2006; 66(12): 6264 - 6270. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-J. Duan, Y. Zhang-Benoit, and G.-H. Fong Endothelium-Intrinsic Requirement for Hif-2{alpha} During Vascular Development Circulation, May 3, 2005; 111(17): 2227 - 2232. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Wang, D. A. Davis, M. Haque, L. E. Huang, and R. Yarchoan Differential Gene Up-Regulation by Hypoxia-Inducible Factor-1{alpha} and Hypoxia-Inducible Factor-2{alpha} in HEK293T Cells Cancer Res., April 15, 2005; 65(8): 3299 - 3306. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Hosford and D. M. Olson Effects of hyperoxia on VEGF, its receptors, and HIF-2{alpha} in the newborn rat lung Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L161 - L168. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Haque, D. A. Davis, V. Wang, I. Widmer, and R. Yarchoan Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Contains Hypoxia Response Elements: Relevance to Lytic Induction by Hypoxia J. Virol., June 15, 2003; 77(12): 6761 - 6768. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liang, X.-Y. Li, E. J. Rebar, P. Li, Y. Zhou, B. Chen, A. P. Wolffe, and C. C. Case Activation of Vascular Endothelial Growth Factor A Transcription in Tumorigenic Glioblastoma Cell Lines by an Enhancer with Cell Type-specific DNase I Accessibility J. Biol. Chem., May 24, 2002; 277(22): 20087 - 20094. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Coleman, J. B. Mitchell, and K. Camphausen Tumor Hypoxia: Chicken, Egg, or a Piece of the Farm? J. Clin. Oncol., February 1, 2002; 20(3): 610 - 615. [Full Text] [PDF] |
||||
![]() |
N. Akeno, J. Robins, M. Zhang, M. F. Czyzyk-Krzeska, and T. L. Clemens Induction of Vascular Endothelial Growth Factor by IGF-I in Osteoblast-Like Cells Is Mediated by the PI3K Signaling Pathway through the Hypoxia-Inducible Factor-2{alpha} Endocrinology, February 1, 2002; 143(2): 420 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Brusselmans, F. Bono, P. Maxwell, Y. Dor, M. Dewerchin, D. Collen, J.-M. Herbert, and P. Carmeliet Hypoxia-inducible Factor-2alpha (HIF-2alpha ) Is Involved in the Apoptotic Response to Hypoglycemia but Not to Hypoxia J. Biol. Chem., October 12, 2001; 276(42): 39192 - 39196. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Gross, N. Akeno, T. L. Clemens, S. Komarova, S. Srinivasan, D. A. Weimer, and S. Mayorov Physiological and Genomic Consequences of Intermittent Hypoxia: Selected Contribution: Osteocytes upregulate HIF-1{alpha} in response to acute disuse and oxygen deprivation J Appl Physiol, June 1, 2001; 90(6): 2514 - 2519. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |